We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-16.73%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$300M
AUM Growth
-$39.4M
Cap. Flow
+$19.1M
Cap. Flow %
6.37%
Top 10 Hldgs %
40.88%
Holding
110
New
17
Increased
29
Reduced
31
Closed
33

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$15.1M
2
AET
Aetna Inc
AET
+$9.05M
3
LAB icon
Standard BioTools
LAB
+$7.23M
4
SPNC
Spectranetics Corp
SPNC
+$6.43M
5
STJ
St Jude Medical
STJ
+$5.86M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$9.99M
2
BCR
CR Bard Inc.
BCR
+$9.92M
3
ELV icon
Elevance Health
ELV
+$6.68M
4
WBA
Walgreens Boots Alliance
WBA
+$6.22M
5
ISRG icon
Intuitive Surgical
ISRG
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 88.86%
2 Financials 3.68%
3 Industrials 1.11%
4 Technology 1.01%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAB icon
26
Standard BioTools
LAB
$340M
$4.04M 1.35%
497,768
+459,568
+1,203% +$7.23M
BIIB icon
27
Biogen
BIIB
$30B
$3.97M 1.33%
13,612
-500
-4% -$165K
HUM icon
28
Humana
HUM
$43.7B
$3.9M 1.3%
21,798
+10,700
+96% +$1.98M
AMAG
29
DELISTED
AMAG Pharmaceuticals
AMAG
$3.74M 1.25%
+94,100
New +$5.84M
BCR
30
DELISTED
CR Bard Inc.
BCR
$3.71M 1.24%
19,899
-52,400
-72% -$9.92M
LH icon
31
Labcorp
LH
$25B
$3.69M 1.23%
39,567
-96,612
-71% -$9.99M
KND
32
DELISTED
Kindred Healthcare
KND
$3.64M 1.21%
230,900
+99,400
+76% +$2.01M
RVTY icon
33
Revvity
RVTY
$12.6B
$3.59M 1.2%
+78,100
New +$3.88M
CI icon
34
Cigna
CI
$73.7B
$3.42M 1.14%
25,300
+13,100
+107% +$1.9M
HMSY
35
DELISTED
HMS Holdings Corp.
HMSY
$3.33M 1.11%
+379,863
New +$4.24M
ZBH icon
36
Zimmer Biomet
ZBH
$18.2B
$3.17M 1.06%
34,711
+9,064
+35% +$909K
GILD icon
37
Gilead Sciences
GILD
$162B
$3.04M 1.02%
31,000
-23,800
-43% -$2.64M
CSLT
38
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.02M 1.01%
718,208
+391,985
+120% +$2.47M
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$121B
$2.78M 0.93%
26,700
-6,200
-19% -$797K
GI
40
DELISTED
EndoChoice Holdings, Inc.
GI
$2.5M 0.83%
219,686
-108,815
-33% -$1.7M
HZNP
41
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.39M 0.8%
+120,700
New +$3.81M
CELG
42
DELISTED
Celgene Corp
CELG
$2.28M 0.76%
21,100
+640
+3% +$79.4K
AMGN icon
43
Amgen
AMGN
$208B
$2.19M 0.73%
15,800
+6,600
+72% +$1.04M
BHC icon
44
Bausch Health
BHC
$2.58B
$2.05M 0.68%
11,500
-8,600
-43% -$2.01M
CYH icon
45
Community Health Systems
CYH
$393M
$1.86M 0.62%
+52,635
New +$2.41M
TNDM icon
46
Tandem Diabetes Care
TNDM
$1.34B
$1.85M 0.62%
21,009
-24,116
-53% -$2.81M
SHPG
47
DELISTED
Shire pic
SHPG
$1.83M 0.61%
+8,900
New +$2.12M
XRAY icon
48
Dentsply Sirona
XRAY
$2.68B
$1.73M 0.58%
34,162
-59,538
-64% -$3.17M
MCK icon
49
McKesson
MCK
$100B
$1.7M 0.57%
9,169
-13,566
-60% -$2.88M
PARN
50
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.49M 0.5%
433,866
+26,723
+7% +$113K
1
2
3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Endurant Capital Management held 110 positions worth $300M, down 12% from $339M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Endurant Capital Management deployed $19.1M of net new capital in Q3 2015, opening 17 new positions and adding to 29 existing holdings. Its largest new stake was AMAG Pharmaceuticals: 94,100 shares worth $3.74M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 90% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Labcorp, an estimated $9.99M trimmed.

  • Endurant Capital Management's largest Q3 2015 buy was AMAG Pharmaceuticals: 94,100 shares worth $3.74M.
  • Endurant Capital Management added most to MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2015, an estimated $15.1M increase.
  • Endurant Capital Management's biggest Q3 2015 reduction was Labcorp, cutting an estimated $9.99M.
  • Endurant Capital Management fully exited Elevance Health in Q3 2015, selling an estimated $6.68M.
  • Endurant Capital Management's ten largest holdings make up 41% of its $300M portfolio in Q3 2015.
  • Endurant Capital Management opened 17 new positions and closed 33 in Q3 2015.
  • Endurant Capital Management's portfolio value fell 12% quarter-over-quarter to $300M.

Based on Endurant Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.